New diabetes clinical trial: SGLT2i Effect on PTDM Development and Kidney Allograft Function in Non-diabetic Kidney Transplant Recipients: A Randomized, Doubleblind, Placebo Controlled, National Multicenter Trial
Published on: 2026-07-02T04:00:00Z Conditions : Kidney Transplant Recipient; Sodium Glucose Co-Transporter 2 Inhibitors; Non-Diabetic Patients; Randomized Controlled Trial (RCT); Placebo Control Design; Post Transplant Diabetes Mellitus Interventions : Drug: SGLT2i; Drug: Placebo Sponsors : Odense University Hospital; Aarhus University Hospital; Copenhagen University Hospital, Denmark Not yet recruiting https://ift.tt/6I1A4Zt